KROS
Price
$15.59
Change
+$0.04 (+0.26%)
Updated
Sep 5 closing price
Capitalization
633.19M
54 days until earnings call
SPHDF
Price
$18.40
Change
+$3.65 (+24.75%)
Updated
Jul 28 closing price
Capitalization
229.36M
Interact to see
Advertisement

KROS vs SPHDF

Header iconKROS vs SPHDF Comparison
Open Charts KROS vs SPHDFBanner chart's image
Keros Therapeutics
Price$15.59
Change+$0.04 (+0.26%)
Volume$537.58K
Capitalization633.19M
Santhera Pharmaceuticals Holdings
Price$18.40
Change+$3.65 (+24.75%)
Volume$600
Capitalization229.36M
KROS vs SPHDF Comparison Chart in %
Loading...
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPHDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KROS vs. SPHDF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KROS is a StrongBuy and SPHDF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (KROS: $15.59 vs. SPHDF: $18.40)
Brand notoriety: KROS and SPHDF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KROS: 116% vs. SPHDF: 124%
Market capitalization -- KROS: $633.19M vs. SPHDF: $229.36M
KROS [@Biotechnology] is valued at $633.19M. SPHDF’s [@Biotechnology] market capitalization is $229.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KROS’s FA Score shows that 1 FA rating(s) are green whileSPHDF’s FA Score has 1 green FA rating(s).

  • KROS’s FA Score: 1 green, 4 red.
  • SPHDF’s FA Score: 1 green, 4 red.
According to our system of comparison, SPHDF is a better buy in the long-term than KROS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KROS’s TA Score shows that 6 TA indicator(s) are bullish while SPHDF’s TA Score has 2 bullish TA indicator(s).

  • KROS’s TA Score: 6 bullish, 4 bearish.
  • SPHDF’s TA Score: 2 bullish, 1 bearish.
According to our system of comparison, KROS is a better buy in the short-term than SPHDF.

Price Growth

KROS (@Biotechnology) experienced а +2.50% price change this week, while SPHDF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Reported Earning Dates

KROS is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KROS($633M) has a higher market cap than SPHDF($229M). KROS has higher P/E ratio than SPHDF: KROS (48.72) vs SPHDF (2.53). SPHDF YTD gains are higher at: 95.329 vs. KROS (-1.516).
KROSSPHDFKROS / SPHDF
Capitalization633M229M276%
EBITDA25.5MN/A-
Gain YTD-1.51695.329-2%
P/E Ratio48.722.531,928%
Revenue233MN/A-
Total Cash690MN/A-
Total Debt18MN/A-
FUNDAMENTALS RATINGS
SPHDF: Fundamental Ratings
SPHDF
OUTLOOK RATING
1..100
45
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
12
SEASONALITY SCORE
1..100
19

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KROSSPHDF
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
33%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
65%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
12%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
14%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
N/A
Declines
ODDS (%)
Bearish Trend 9 days ago
80%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
83%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
18%
View a ticker or compare two or three
Interact to see
Advertisement
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPHDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CBAIX48.92N/A
N/A
Calvert Balanced I
CTSOX43.97N/A
N/A
Calamos Timpani Small Cap Growth R6
UIVIX13.03N/A
N/A
MFS Intrinsic Value I
VSIEX22.41N/A
N/A
JPMorgan International Equity I
MGFZX10.67N/A
N/A
MassMutual Global I

SPHDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPHDF has been closely correlated with TRML. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if SPHDF jumps, then TRML could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPHDF
1D Price
Change %
SPHDF100%
N/A
TRML - SPHDF
78%
Closely correlated
+6.53%
COGT - SPHDF
63%
Loosely correlated
+0.85%
MEOBF - SPHDF
50%
Loosely correlated
N/A
KROS - SPHDF
38%
Loosely correlated
+0.26%
CYTOF - SPHDF
35%
Loosely correlated
N/A
More